Rh type is a classification on your blood test that tells you whether your red blood cells carry a specific inherited protein on their surface. If the protein is present, you’re Rh positive. If it’s absent, you’re Rh negative. About 77% of people are Rh positive, making it the more common result. Your Rh type matters most in two situations: blood transfusions and pregnancy.
What Rh Type Actually Measures
Your blood type has two parts. The first is the ABO group (A, B, AB, or O), which describes the sugar molecules on your red blood cells. The second is your Rh type, which describes whether those cells carry the Rh D protein. When your blood test result says something like “O positive” or “A negative,” the positive or negative refers to your Rh status.
The Rh protein is determined entirely by genetics. You inherit it (or don’t) from your parents. It doesn’t change over your lifetime, and nothing you eat, do, or are exposed to will alter it. Once you know your Rh type, you know it permanently.
How the Test Works
Rh typing is straightforward and usually done alongside your ABO blood type from a standard blood draw. In the lab, a small sample of your blood is mixed with a reagent that reacts specifically to the Rh D protein. If your red blood cells clump together (a process called agglutination), the protein is present and you’re Rh positive. If they don’t clump, you’re Rh negative.
Some people have a weakened version of the D protein that doesn’t always show up on the first pass. In those cases, the lab runs an additional step, incubating the sample longer and adding a secondary reagent to confirm the result. This two-method approach helps catch borderline cases that might otherwise be mistyped.
Rh Distribution by Blood Type
Rh-positive blood is far more common than Rh-negative across every ABO group, but the split varies. Based on data from blood donation services, the approximate breakdown looks like this:
- O positive: 36% of the population
- O negative: 14%
- A positive: 28%
- A negative: 8%
- B positive: 8%
- B negative: 3%
- AB positive: 2%
- AB negative: 1%
These numbers vary by ethnicity and geographic region. Rh-negative blood is most common in people of European descent and rarest in East Asian and African populations.
Why Rh Type Matters for Transfusions
If you receive a blood transfusion, your Rh type determines which donor blood is safe for you. Rh-negative patients should receive Rh-negative blood. Rh-positive patients can safely receive either Rh-positive or Rh-negative blood. This is why O negative is considered the universal red cell donor type: it lacks both the ABO sugar molecules and the Rh protein, so virtually anyone can receive it in an emergency.
If an Rh-negative person receives Rh-positive blood, their immune system may recognize the Rh protein as foreign and start producing antibodies against it. This isn’t always immediately dangerous, but it creates a lasting immune memory. Any future exposure to Rh-positive blood could then trigger a serious reaction where those antibodies attack the transfused red blood cells.
Rh Type in Pregnancy
This is where Rh typing carries the highest stakes. If you’re pregnant and Rh negative, but your baby inherits the Rh protein from the father and is Rh positive, a condition called Rh incompatibility can develop. During pregnancy or delivery, small amounts of the baby’s blood can cross through the placenta into your bloodstream. As little as 0.1 mL of fetal blood is enough to trigger your immune system to start building antibodies against the Rh protein.
In a first pregnancy, this sensitization process usually happens too late to harm that baby. The initial antibodies your body produces are a type that can’t cross the placenta. The real danger comes with subsequent pregnancies. If your next baby is also Rh positive, your immune system recognizes the protein immediately and produces a different, smaller antibody that crosses the placenta freely. These antibodies attack and destroy the baby’s red blood cells.
The destruction of red blood cells releases bilirubin, a yellow waste product, into the baby’s blood. Mild cases cause jaundice, the yellowing of the skin and eyes that many newborns experience temporarily. Severe cases can lead to dangerous levels of bilirubin that damage the brain, a condition called kernicterus. In the most extreme form, the baby develops widespread swelling and fluid buildup, known as hydrops fetalis, which can be life-threatening. Affected newborns may also show low muscle tone, lethargy, and problems with movement and hearing.
How Rh Incompatibility Is Prevented
The standard prevention is an injection of Rh immunoglobulin, commonly known by the brand name RhoGAM, given to Rh-negative mothers during and after pregnancy. This injection contains ready-made antibodies that neutralize any fetal Rh-positive blood cells in the mother’s system before her own immune system has a chance to react. It’s given as a routine shot between weeks 26 and 28 of pregnancy, then again within 72 hours of delivering an Rh-positive baby.
If you experience a miscarriage, an ectopic pregnancy, or any event during pregnancy that could cause fetal blood to mix with yours, the injection is recommended within 72 hours of that event as well. For ongoing pregnancies, it may be repeated every 12 weeks to maintain protection. If the window is missed after delivery, partial protection is still possible up to 13 days later, with some benefit seen as far out as 28 days, though the longer the delay, the less effective it becomes.
This preventive approach has been remarkably successful. Before it became standard practice in the late 1960s, Rh incompatibility was a leading cause of newborn illness and death. Today, severe cases are rare in countries where routine Rh screening and immunoglobulin treatment are available.
The Rarest Rh Type
Beyond the simple positive/negative classification, the Rh system actually involves several related proteins (labeled C, c, D, E, and e). In extremely rare cases, a person’s red blood cells lack all of them. This phenotype, sometimes called “golden blood,” has been identified in only a small number of people worldwide. Individuals with this blood type face a unique medical challenge: they can only safely receive blood from other people who share their phenotype, making transfusions extraordinarily difficult to arrange. They also tend to have fragile red blood cells that break down more easily, leading to mild chronic anemia.